-
Next-Generation Challenges
Cost of Illness, Big Data, and Litigation
From the rising impact of diseases such as depression and obesity to the rapid expansion of medical data, many of the challenges facing global health care systems represent new aspects of foundational issues. In this Bulletin, leaders of Analysis Group’s Health Care practice draw on their experience and research to offer insights to improve decision making and outcomes.
-
Health Care Bulletin
The Growing Economic Burden of Depression in the United States
The economic ripples of major depressive disorder (MDD) are extensive and disproportionate to the amount spent on the disease itself.
-
Health Care Bulletin
Developments in Medical Big Data Research: What Makes Data Different Today?
The use of big data and related analytics is increasingly widespread in health care. In a recent conversation, Senior Advisor Howard Birnbaum met with Managing Principals Mei Sheng Duh and Eric Wu to discuss the future of medical big data research.
-
Health Care Bulletin
New Challenges and Initiatives in Big Data Processing
As the quantity of available data increases and traditional processing approaches become cumbersome and costly, Analysis Group teams have utilized a novel approach: leveraging the graphic processing unit (GPU) cores in graphics cards for parallel processing.
-
Health Care Bulletin
The Obesity Epidemic: A New Look at the Urgency, Challenges, and Opportunities
Rising obesity levels are now responsible for more than one-quarter of total health care expenditures in the United States and may become the single largest driver of mortality other than aging.
-
AG Feature
Anti-Obesity Drug Development Risks and Expectations
Despite a large and growing unmet need, anti-obesity drug product launches slowed in the 1990s and early 2000s following a series of withdrawals, failures, and significant litigation settlements.
Also on analysisgroup.com
-
Also on AnalysisGroup.com
-
Leaders of Analysis Group’s Health Care practice have been consistently recognized as industry leaders at leading international conferences and have also been involved in significant trends in health care litigation.
Researchers from Analysis Group's Health Care practice presented one educational symposium and one workshop, and exhibited 24 posters, at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual International Meeting. Three posters supported by Analysis Group researchers received finalist ribbons. The research, covering tuberous sclerosis complex, obesity, and migraines, involved Managing Principals Mei Sheng Duh and Edward Tuttle, Principal Howard Birnbaum, Vice Presidents Noam Kirson and Francis Vekeman, and Managers Rajeev Ayyagari and Amie Shei.
In August 2015, a group of prominent economists that included senior staff members Bruce Stangle, Paul Greenberg, Pierre Cremieux, and George Kosicki, and academic economists James Hughes, Keith Hylton, Edward Snyder, and Michael Wohlgenant filed an amicus curiae brief regarding issues in the antitrust treatment of pharmaceutical patent infringement settlements. In January 2015, senior firm members Bruce Stangle and Paul Greenberg, and academic economists Henry Grabowski, James Hughes, John Rizzo, Edward Snyder, and Michael Wohlgenant, filed an amicus curiae brief regarding a pharmaceutical manufacturer’s freedom to withdraw a branded product from the market prior to generic entry.
-